T Sakari Jokiranta Selected Research

T Sakari Jokiranta Research Topics

Disease

13	Atypical Hemolytic Uremic Syndrome 01/2021 - 03/2006
5	Infections 01/2017 - 09/2003
5	Macular Degeneration (Age-Related Maculopathy) 01/2017 - 09/2006
2	Lyme Disease (Disease, Lyme) 03/2021 - 06/2013
2	Inflammation (Inflammations) 01/2018 - 03/2007
2	Thrombotic Microangiopathies 10/2012 - 06/2009
2	Membranoproliferative Glomerulonephritis (Membranoproliferative Glomerulonephritis, Type II) 09/2007 - 09/2006
1	Nervous System Diseases (Neurological Disorders) 11/2023
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 08/2021
1	Neuromyelitis Optica (Devic's Disease) 01/2021
1	Dientamoebiasis 07/2019
1	Giardiasis 07/2019
1	Hemolysis 01/2019
1	Psoriasis (Pustulosis Palmaris et Plantaris) 10/2018
1	Tonsillitis 10/2018
1	Atherosclerosis 01/2018
1	Convalescence 01/2017
1	Neoplasms (Cancer) 01/2017
1	Rheumatoid Arthritis 01/2016
1	Paraproteinemias (Monoclonal Gammopathy) 06/2015
1	Systemic Scleroderma (Systemic Sclerosis) 01/2015
1	Thrombosis (Thrombus) 01/2014
1	Gonorrhea 06/2011
1	Whooping Cough (Pertussis) 01/2011
1	Babesiosis (Piroplasmosis) 07/2010
1	Hereditary Complement Deficiency Diseases 09/2007
1	Proteinuria 09/2007
1	Rare Diseases (Rare Disease) 09/2007
1	Blindness (Hysterical Blindness) 09/2006
1	Urinary Bladder Neoplasms (Bladder Cancer) 05/2005
1	Vaccinia 04/2003
1	Intestinal Volvulus (Volvulus) 06/2002

Drug/Important Bio-Agent (IBA)

16	Complement System Proteins (Complement)IBA 01/2021 - 06/2002
14	Complement Factor H (Factor H)IBA 01/2021 - 05/2005
8	AutoantibodiesIBA 01/2021 - 10/2012
6	Proteins (Proteins, Gene)FDA Link 01/2021 - 04/2003
3	EpitopesIBA 01/2017 - 04/2015
2	VaccinesIBA 11/2023 - 09/2003
2	Peptides (Polypeptides)IBA 01/2017 - 11/2011
2	LigandsIBA 01/2017 - 05/2005
1	vedolizumabIBA 08/2021
1	N 30IBA 03/2021
1	Aquaporin 4IBA 01/2021
1	Aquaporins (Water Channels)IBA 01/2021
1	Formaldehyde (Formol)FDA Link 07/2019
1	Neuraminidase (Sialidase)IBA 01/2019
1	HLA-B57 antigenIBA 10/2018
1	Biomarkers (Surrogate Marker)IBA 10/2018
1	HLA-C Antigens (HLA-C)IBA 10/2018
1	Apolipoproteins E (ApoE)IBA 01/2018
1	ApolipoproteinsIBA 01/2018
1	Amino Acids FDA Link 01/2017
1	Infliximab (Remicade)FDA Link 01/2016
1	N-Acetylneuraminic Acid (Sialic Acid)IBA 01/2016
1	Adalimumab (Humira)FDA Link 01/2016
1	AntibodiesIBA 01/2016
1	Complement C3 Nephritic FactorIBA 06/2015
1	factor H-related protein 1IBA 04/2015
1	Malondialdehyde (Propanedial)IBA 02/2014
1	LipidsIBA 11/2011
1	Apolipoprotein A-I (Apolipoprotein A1)IBA 11/2011
1	Anti-Bacterial Agents (Antibiotics)IBA 06/2011
1	GlycosaminoglycansIBA 02/2011
1	Complement C4b-Binding ProteinIBA 01/2011
1	Rituximab (Mabthera)FDA Link 09/2007
1	glucuronyl glucosamine glycan sulfate (sulodexide)IBA 09/2007
1	Dichlorodiphenyldichloroethane (DDD)IBA 09/2007
1	eculizumab FDA Link 09/2007
1	C-Reactive ProteinIBA 03/2007
1	Retinaldehyde (Retinal)IBA 03/2007
1	Acute-Phase Proteins (Acute-Phase Protein)IBA 03/2007
1	Tumor Biomarkers (Tumor Markers)IBA 05/2005
1	Monoclonal AntibodiesIBA 05/2005
1	Complement C3b (C3bi)IBA 06/2002

Therapy/Procedure

1	Tonsillectomy 10/2018
1	Transplantation 01/2017
1	Splenectomy 07/2010